• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Bcl-x短异构体对于维持多种组织的稳态至关重要。

Bcl-x short-isoform is essential for maintaining homeostasis of multiple tissues.

作者信息

Keller Mariko Aoyagi, Huang Chun-Yang, Ivessa Andreas, Singh Sukhwinder, Romanienko Peter J, Nakamura Michinari

机构信息

Department of Cell Biology and Molecular Medicine, Rutgers New Jersey Medical School, Newark, NJ 07103, USA.

Division of Cardiovascular Surgery, Department of Surgery, Taipei Veterans General Hospital, Taipei, 112, Taiwan.

出版信息

iScience. 2023 Mar 16;26(4):106409. doi: 10.1016/j.isci.2023.106409. eCollection 2023 Apr 21.

DOI:10.1016/j.isci.2023.106409
PMID:37035008
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10074800/
Abstract

BCL-2-like protein 1 (BCL2L1) is a key component of cell survival and death mechanisms. Its dysregulation and altered ratio of splicing variants associate with pathologies. However, isoform-specific loss-of-function analysis of BCL2L1 remains unexplored. Here we show the functional impact of genetically inhibiting Bcl-x short-isoform (Bcl-xS) . Bcl-xS is expressed in most tissues with predominant expression in the spleen and blood cells in mice. Bcl-xS knockout (KO) mice show no overt abnormality until 3 months of age. Thereafter, KO mice develop cardiac hypertrophy with contractile dysfunction and splenomegaly by 6 months. Cardiac fibrosis significantly increases in KO, but the frequency of apoptosis is indistinguishable despite cardiomyopathy. The Akt/mTOR and JNK/cJun signaling are upregulated in male KO heart, and the JNK/cJun is activated with increased Bax expression in KO spleen. These results suggest that Bcl-xS may be dispensable for development but is essential for maintaining the homeostasis of multiple organs.

摘要

BCL-2样蛋白1(BCL2L1)是细胞存活和死亡机制的关键组成部分。其失调以及剪接变体比例的改变与多种病理状况相关。然而,BCL2L1亚型特异性功能丧失分析仍未得到探索。在此,我们展示了基因抑制Bcl-x短亚型(Bcl-xS)的功能影响。Bcl-xS在大多数组织中表达,在小鼠的脾脏和血细胞中表达尤为显著。Bcl-xS基因敲除(KO)小鼠在3个月龄前未表现出明显异常。此后,KO小鼠在6个月时出现心脏肥大并伴有收缩功能障碍以及脾肿大。KO小鼠的心脏纤维化显著增加,尽管存在心肌病,但细胞凋亡频率并无差异。雄性KO心脏中Akt/mTOR和JNK/cJun信号上调,KO脾脏中JNK/cJun激活且Bax表达增加。这些结果表明,Bcl-xS对于发育可能并非必需,但对于维持多个器官的稳态至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b027/10074800/03b04642a6a1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b027/10074800/03b04642a6a1/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b027/10074800/03b04642a6a1/fx1.jpg

相似文献

1
Bcl-x short-isoform is essential for maintaining homeostasis of multiple tissues.Bcl-x短异构体对于维持多种组织的稳态至关重要。
iScience. 2023 Mar 16;26(4):106409. doi: 10.1016/j.isci.2023.106409. eCollection 2023 Apr 21.
2
Modulation of the Apoptosis Gene Bcl-x Function Through Alternative Splicing.通过可变剪接对凋亡基因Bcl-x功能的调控
Front Genet. 2019 Sep 6;10:804. doi: 10.3389/fgene.2019.00804. eCollection 2019.
3
Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells.Bax和Bcl-xs在退化的乳腺上皮细胞凋亡开始时被诱导产生。
Mech Dev. 1996 May;56(1-2):197-207. doi: 10.1016/0925-4773(96)88032-4.
4
Regulation of alternative splicing of Bcl-x by BC200 contributes to breast cancer pathogenesis.BC200对Bcl-x可变剪接的调控有助于乳腺癌的发病机制。
Cell Death Dis. 2016 Jun 9;7(6):e2262. doi: 10.1038/cddis.2016.168.
5
Predominant expression of the long isoform of Bcl-x (Bcl-xL) in human lymphomas.Bcl-x长亚型(Bcl-xL)在人类淋巴瘤中的主要表达
Br J Haematol. 1996 Mar;92(4):900-6. doi: 10.1046/j.1365-2141.1996.423958.x.
6
Bcl-xS and Bax induce different apoptotic pathways in PC12 cells.Bcl-xS和Bax在PC12细胞中诱导不同的凋亡途径。
Oncogene. 2000 Mar 30;19(14):1783-93. doi: 10.1038/sj.onc.1203495.
7
Apoptosis in Cancer Cells Is Induced by Alternative Splicing of hnRNPA2/B1 Through Splicing of Bcl-x, a Mechanism that Can Be Stimulated by an Extract of the South African Medicinal Plant, .通过Bcl-x剪接,hnRNPA2/B1的可变剪接诱导癌细胞凋亡,这是一种可被南非药用植物提取物刺激的机制。
Front Oncol. 2020 Oct 8;10:547392. doi: 10.3389/fonc.2020.547392. eCollection 2020.
8
Developmental consequences of alternative Bcl-x splicing during preimplantation embryo development.胚胎植入前发育过程中 Bcl-x 剪接方式改变的发育后果。
FEBS J. 2010 Mar;277(5):1219-33. doi: 10.1111/j.1742-4658.2010.07554.x. Epub 2010 Feb 3.
9
Long non-coding RNA INXS is a critical mediator of BCL-XS induced apoptosis.长链非编码RNA INXS是BCL-XS诱导凋亡的关键介质。
Nucleic Acids Res. 2014 Jul;42(13):8343-55. doi: 10.1093/nar/gku561. Epub 2014 Jul 3.
10
Biophysical characterisation of the Bcl-x pre-mRNA and binding specificity of the ellipticine derivative GQC-05: Implication for alternative splicing regulation.Bcl-x前体mRNA的生物物理特性及玫瑰树碱衍生物GQC-05的结合特异性:对可变剪接调控的意义
Front Mol Biosci. 2022 Aug 17;9:943105. doi: 10.3389/fmolb.2022.943105. eCollection 2022.

引用本文的文献

1
Detection of mRNA Transcript Variants.mRNA转录变体的检测
Genes (Basel). 2025 Mar 16;16(3):343. doi: 10.3390/genes16030343.
2
Multiple roles of mitochondrial autophagy receptor FUNDC1 in mitochondrial events and kidney disease.线粒体自噬受体FUNDC1在线粒体事件和肾脏疾病中的多重作用
Front Cell Dev Biol. 2024 Oct 9;12:1453365. doi: 10.3389/fcell.2024.1453365. eCollection 2024.
3
Protein isoform-centric therapeutics: expanding targets and increasing specificity.以蛋白质亚型为中心的治疗策略:扩大靶点,提高特异性。

本文引用的文献

1
Alternative splicing as a source of phenotypic diversity.可变剪接作为表型多样性的一个来源。
Nat Rev Genet. 2022 Nov;23(11):697-710. doi: 10.1038/s41576-022-00514-4. Epub 2022 Jul 12.
2
Dysregulation and therapeutic targeting of RNA splicing in cancer.癌症中 RNA 剪接的失调和治疗靶标。
Nat Cancer. 2022 May;3(5):536-546. doi: 10.1038/s43018-022-00384-z. Epub 2022 May 27.
3
Deficiency of the splicing factor RBM10 limits EGFR inhibitor response in EGFR-mutant lung cancer.剪接因子RBM10的缺陷限制了EGFR突变型肺癌对EGFR抑制剂的反应。
Nat Rev Drug Discov. 2024 Oct;23(10):759-779. doi: 10.1038/s41573-024-01025-z. Epub 2024 Sep 4.
4
Lipotoxicity as a therapeutic target in obesity and diabetic cardiomyopathy.脂毒性作为肥胖和糖尿病性心肌病的治疗靶点。
J Pharm Pharm Sci. 2024 Apr 19;27:12568. doi: 10.3389/jpps.2024.12568. eCollection 2024.
5
Design, Synthesis, and Potent Anticancer Activity of Novel Indole-Based Bcl-2 Inhibitors.新型吲哚基 Bcl-2 抑制剂的设计、合成及抗肿瘤活性研究。
Int J Mol Sci. 2023 Sep 28;24(19):14656. doi: 10.3390/ijms241914656.
6
Ser14 phosphorylation of Bcl-xL mediates compensatory cardiac hypertrophy in male mice.Bcl-xL 的丝氨酸 14 位磷酸化介导雄性小鼠的代偿性心肌肥厚。
Nat Commun. 2023 Sep 19;14(1):5805. doi: 10.1038/s41467-023-41595-x.
J Clin Invest. 2022 Jul 1;132(13). doi: 10.1172/JCI145099.
4
Co-targeting of BAX and BCL-XL proteins broadly overcomes resistance to apoptosis in cancer.靶向 BAX 和 BCL-XL 蛋白广泛克服癌症的凋亡抵抗。
Nat Commun. 2022 Mar 7;13(1):1199. doi: 10.1038/s41467-022-28741-7.
5
BCL-XL inhibition induces an FGFR4-mediated rescue response in colorectal cancer.BCL-XL 抑制诱导结直肠癌中 FGFR4 介导的挽救反应。
Cell Rep. 2022 Feb 15;38(7):110374. doi: 10.1016/j.celrep.2022.110374.
6
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
7
Development of a BCL-xL and BCL-2 dual degrader with improved anti-leukemic activity.开发一种具有增强抗白血病活性的 BCL-xL 和 BCL-2 双降解剂。
Nat Commun. 2021 Nov 25;12(1):6896. doi: 10.1038/s41467-021-27210-x.
8
Ensembl 2022.Ensembl 2022.
Nucleic Acids Res. 2022 Jan 7;50(D1):D988-D995. doi: 10.1093/nar/gkab1049.
9
Massively parallel assessment of human variants with base editor screens.基于碱基编辑器的高通量人类变异评估。
Cell. 2021 Feb 18;184(4):1064-1080.e20. doi: 10.1016/j.cell.2021.01.012.
10
Dietary carbohydrates restriction inhibits the development of cardiac hypertrophy and heart failure.饮食中碳水化合物的限制可抑制心肌肥厚和心力衰竭的发展。
Cardiovasc Res. 2021 Sep 28;117(11):2365-2376. doi: 10.1093/cvr/cvaa298.